Different effects of cyclosporine and tacrolimus on the activation of mesangial metalloproteinases and their inhibitors

By Hampel G.   Hosseini R.   Jung K.  

Transplantation Proceedings, Vol. 31, Iss. 7, 1999-11 ,pp. : 2757-2758

Elsevier

Access to resources Recommend Favorite

Tacrolimus use in kidney-pancreas recipients is associated with less acute renal dysfunction than cyclosporine

By Fleck P.R.   Schroeder T.J.   Dauod A.J.   Peddi V.R.   First M.R.  

Transplantation Proceedings, Vol. 30, Iss. 8, 1998-12 ,pp. : 4070-4072

Elsevier

Access to resources Recommend Favorite

Conversion from cyclosporine to tacrolimus in renal allograft recipients with delayed graft function from severe acute tubular necrosis

By Jang H.J.   Kim S.C.   Han D.J.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 1714-1715

Elsevier

Access to resources Recommend Favorite

Tacrolimus-Basiliximab versus Cyclosporine-Basiliximab in renal transplantation ''de novo'': acute rejection and complications

By Garcia D.M.   Gago J.M.   Mendiluce A.   Gordillo R.   Bustamente J.  

Transplantation Proceedings, Vol. 35, Iss. 5, 2003-08 ,pp. : 1694-1696

Elsevier

Access to resources Recommend Favorite

Conversion from cyclosporine to tacrolimus for refractory acute rejection in pediatric kidney transplant recipients: a single-center experience

By Ferraresso M.   Ghio L.   Edefonti A.   Garavaglia R.   Pozzoli E.   Berardinelli L.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3590-3591

Elsevier

Access to resources Recommend Favorite